GlobalData on MSN6h
Shionogi awarded $375m from HHS for preventative Covid-19 injectable
Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...
Cautious Outlook on Apellis Pharmaceuticals Amid Sales Success and Competitive Challenges
Mizuho Securities analyst Graig Suvannavejh has maintained their neutral stance on APLS stock, giving a Hold rating on January 14.Stay Ahead ...